Similar companies
Company | Business Outlook | |
---|---|---|
AmgenAMGN |
76 0% | |
Gilead SciencesGILD |
63 1.6% | |
Catalyst PharmaceuticalsCPRX |
100 0% | |
Inovio PharmaceuticalsINO |
18 5.3% | |
Anavex Life SciencesAVXL |
0 |
Month over Month
Employee view on business outlook (0 - 100)
Aug 2024 | 41 | |
Jul 2024 | 41 | |
Jun 2024 | 41 | |
May 2024 | 41 |
How do employees feel about the future at Bluebird bio?
The Business Outlook at Bluebird bio is negative, according to employees. The rating, which is an average compiled from the top review sites in the US, is below average at 44 out of 100. Additionally, this rating has been trending downward in comparison to the previous month. But the rating is up, compared to previous month.
Analyzing Business Outlook, how is Bluebird bio performing compared to its industry peers?
Compared to its peers, Bluebird bio ranks in the 44th percentile when it comes to Business Outlook.
How has the business outlook at Bluebird bio changed over the last couple of months
In recent months, Bluebird bio's employees have reported a shift towards a more positive business outlook, indicating improved company morale and potentially leading to increased market competitiveness and enhanced company performance.
Why is it important to track the business outlook at Bluebird bio?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Bluebird bio.